The neurochip: a new multielectrode device for stimulating and recording from cultured neurons MP Maher, J Pine, J Wright, YC Tai
Journal of neuroscience methods 87 (1), 45-56, 1999
448 1999 High throughput method and system for screening candidate compounds for activity against target ion channels MP Maher, JE Gonzalez III
US Patent 6,686,193, 2004
232 2004 Multi-well plate and electrode assemblies for ion channel assays MP Maher, JE Gonzalez III
US Patent 6,969,449, 2005
172 2005 Charge-density-wave pinning and finite-size effects in J McCarten, DA DiCarlo, MP Maher, TL Adelman, RE Thorne
Physical Review B 46 (8), 4456, 1992
167 1992 Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential CJ Huang, A Harootunian, MP Maher, C Quan, CD Raj, K McCormack, ...
Nature biotechnology 24 (4), 439-446, 2006
160 2006 Cellular fluorescent indicators and voltage/ion probe reader (VIPR TM): Tools for ion channel and receptor drug discovery JE González, MP Maher
Receptors and Channels 8 (5-6), 283-295, 2002
119 2002 Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis KM Feeley, JF Fullard, MA Heneghan, T Smith, M Maher, RP Murphy, ...
The Journal of pathology 188 (1), 14-17, 1999
104 1999 Phase slip in charge-density-wave systems S Ramakrishna, MP Maher, V Ambegaokar, U Eckern
Physical review letters 68 (13), 2066, 1992
101 1992 Ion channel assay methods MP Maher, JE Gonzalez III
US Patent 7,615,357, 2009
100 2009 Discovery and characterization of AMPA receptor modulators selective for TARP-γ8 MP Maher, N Wu, S Ravula, MK Ameriks, BM Savall, C Liu, B Lord, ...
Journal of Pharmacology and Experimental Therapeutics 357 (2), 394-414, 2016
99 2016 Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient … A Bhattacharya, BP Scott, N Nasser, H Ao, MP Maher, AE Dubin, ...
Journal of Pharmacology and Experimental Therapeutics 323 (2), 665-674, 2007
91 2007 Activation of TRPA1 by farnesyl thiosalicylic acid M Maher, H Ao, T Banke, N Nasser, NT Wu, JG Breitenbucher, ...
Molecular Pharmacology 73 (4), 1225-1234, 2008
86 2008 Size effects and charge-density-wave pinning in NbSe 3 J McCarten, M Maher, TL Adelman, RE Thorne
Physical review letters 63 (26), 2841, 1989
66 1989 Getting a handle on neuropharmacology by targeting receptor-associated proteins MP Maher, JA Matta, S Gu, M Seierstad, DS Bredt
Neuron 96 (5), 989-1001, 2017
64 2017 HCN pacemaker channels and pain: a drug discovery perspective AD Wickenden, MP Maher, SR Chaplan
Current pharmaceutical design 15 (18), 2149-2168, 2009
54 2009 Microstructures for studies of cultured neural networks MP Maher, H Dvorak-Carbone, J Pine, JA Wright, YC Tai
Medical & biological engineering & computing 37, 110-118, 1999
54 1999 Size effects, phase slip, and the origin of f− α noise in NbSe 3 MP Maher, TL Adelman, J McCarten, DA DiCarlo, RE Thorne
Physical Review B 43 (12), 9968, 1991
50 1991 Charge-density-wave phase slip and current conversion in NbSe 3 MP Maher, TL Adelman, S Ramakrishna, JP McCarten, DA DiCarlo, ...
Physical review letters 68 (20), 3084, 1992
49 1992 Discovery of a novel series of selective HCN1 blockers KJ McClure, M Maher, N Wu, SR Chaplan, WA Eckert III, DH Lee, ...
Bioorganic & medicinal chemistry letters 21 (18), 5197-5201, 2011
41 2011 Recent advances in the biology and medicinal chemistry of TRPA1 JC Rech, WA Eckert, MP Maher, T Banke, A Bhattacharya, AD Wickenden
Future Medicinal Chemistry 2 (5), 843-858, 2010
38 2010 